A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices
Recruiting now
Conditions studied: Acute Coronary Syndromes, Flow Mediated Dilation, Endothelial Function (FMD)
In brief
A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.
Key facts
- Study ID
- NCT06890013
- Run by
- Aristotle University Of Thessaloniki
- People needed
- 100
- Starts
- 2024-06-01
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2026-03-02
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years
- Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)
- Capability of providing written informed consent
- Patients able to comply with the follow-up schedule of the study
You may not qualify if…
- Patients with acute coronary syndromes classified as MINOCA, or type II myocardial infarction
- Patients with rare acute coronary syndrome types, such as spontaneous coronary artery dissection or Takotsubo syndrome
- Patients with congenital heart disease
- Age > 85 years
- Patients with end stage chronic kidney disease
- Patients with active malignancy or autoimmune diseases which limit their survival
- Patients with expected survival < 1 year due to other reasons
- Suboptimal echocardiographic windows
- Inability to provide written consent
- Inability to comply with the follow-up schedule of the study
- Pregnancy
- Use of intravenous drugs
Where it is running
- Ippokratio General Hospital — Thessaloniki, Greece (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.